论文部分内容阅读
应用分子生物学技术研究表明地塞米松，降钙素基因相关肽（ＣＧＲＰ），ＴＨＰ三者在不同环节上拮抗了ＩＬ一１的作用，为在临床上治疗肾小球炎症提供了实验依据。
Studies using molecular biology techniques show that dexamethasone, calcitonin gene related peptide (CGRP), and THP antagonize IL-1 at different stages and provide an experimental basis for the treatment of glomerular inflammation clinically.